BioDuro Appoints Dr. Andrew Thomas and Dr. Stevan Djuric as Scientific Advisors
BioDuro, a leading global contract research, development, and manufacturing organization (CRDMO), today announced the appointment of Andrew Thomas, Ph.D., and Stevan Djuric, Ph.D., as scientific advisors. In these new roles, they will provide strategic guidance to clients, and BioDuro’s scientific and operational teams, helping strengthen the company’s capabilities in innovative drug discovery and development.